hPSC Quality: Essential Considerations for Gene Editing, Cloning, Maintenance and Disease Modeling
With CRISPR-Cas9 technology, generation of genome-edited human pluripotent cell lines has increased. This seminar discusses critical quality control aspects for robust hPSC cultures, exemplified with disease modeling methods using cerebral organoids.
Publish Date: July 13, 2018
Views: 0
Related Multimedia
-
25:30Brains in a Dish: Using Cerebral Organoids to Study Human Brain Development and Disease
Publish Date: July 03, 2017 -
47:18Madeline Lancaster on Brain Organoids: Modeling Human Brain Development in a Dish
Publish Date: September 20, 2017 -
55:53Maintaining and Assessing High-Quality hPSC Cultures
Publish Date: March 12, 2018 -
45:22Data Quality and Standards for Pluripotent Stem Cells
Publish Date: September 28, 2018
Explore Our Products
-
STEMdiff™ Trilineage Differentiation Kit
Functional assay kit to assess pluripotency by directed differentiation of human ES and iPS cells to all three germ layers -
cGMP, feeder-free maintenance medium for human ES and iPS cells -
Enhanced green fluorescent protein (eGFP)-tagged Cas9 nuclease for the generation of double-strand breaks in CRISPR-Cas9 genome editing -
Modified Cas9 nuclease for the generation of single-strand breaks in CRISPR-Cas9 genome editing